Found: 35
Select item for more details and to access through your institution.
<italic>H19</italic> overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia.
- Published in:
- Clinical Epigenetics, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13148-018-0486-z
- By:
- Publication type:
- Article
Clinical Significance of Low Expression of LncRNA CASC15 in Acute Myeloid Leukemia with NPM1 Mutations.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2022, v. 30, n. 3, p. 659, doi. 10.19746/j.cnki.issn1009-2137.2022.03.002
- By:
- Publication type:
- Article
Hypomethylation of MIR‐378 5'‐flanking region predicts poor survival in young patients with myelodysplastic syndrome.
- Published in:
- Molecular Genetics & Genomic Medicine, 2020, v. 8, n. 1, p. N.PAG, doi. 10.1002/mgg3.1067
- By:
- Publication type:
- Article
Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 5, p. 865, doi. 10.1515/cclm-2015-0536
- By:
- Publication type:
- Article
Aberrant hypermethylation of CTNNA1 gene is associated with higher IPSS risk in patients with myelodysplastic syndrome.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2014, v. 52, n. 12, p. 1859, doi. 10.1515/cclm-2014-0446
- By:
- Publication type:
- Article
Low SOX17 expression: prognostic significance in de novo acute myeloid leukemia with normal cytogenetics.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2014, v. 52, n. 12, p. 1843, doi. 10.1515/cclm-2014-0487
- By:
- Publication type:
- Article
Methylation‐independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 12, p. 9584, doi. 10.1002/jcp.26866
- By:
- Publication type:
- Article
SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia.
- Published in:
- Clinical Epigenetics, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13148-022-01373-w
- By:
- Publication type:
- Article
Detection of SRSF2-P95 Mutation by High-Resolution Melting Curve Analysis and Its Effect on Prognosis in Myelodysplastic Syndrome.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0115693
- By:
- Publication type:
- Article
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
- Published in:
- Diagnostic Pathology, 2019, v. 14, n. 1, p. 1, doi. 10.1186/s13000-019-0841-1
- By:
- Publication type:
- Article
ALOX5AP is a new prognostic indicator in acute myeloid leukemia.
- Published in:
- Discover Oncology, 2023, v. 14, n. 1, p. 1, doi. 10.1007/s12672-023-00826-9
- By:
- Publication type:
- Article
Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 789, doi. 10.1002/cam4.4905
- By:
- Publication type:
- Article
GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 267, doi. 10.1002/cam4.984
- By:
- Publication type:
- Article
Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 2, p. 1, doi. 10.1002/ctm2.29
- By:
- Publication type:
- Article
EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 2, p. 1640, doi. 10.1111/jcmm.14855
- By:
- Publication type:
- Article
Establishment and molecular characterization of decitabine‐resistant K562 cells.
- Published in:
- Journal of Cellular & Molecular Medicine, 2019, v. 23, n. 5, p. 3317, doi. 10.1111/jcmm.14221
- By:
- Publication type:
- Article
Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
- Published in:
- Journal of Cellular & Molecular Medicine, 2017, v. 21, n. 8, p. 1468, doi. 10.1111/jcmm.13073
- By:
- Publication type:
- Article
Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.717527
- By:
- Publication type:
- Article
DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 11, p. 1, doi. 10.1038/s41419-020-03213-2
- By:
- Publication type:
- Article
Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia.
- Published in:
- Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01013-9
- By:
- Publication type:
- Article
Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0165948
- By:
- Publication type:
- Article
Decreased <italic>SCIN</italic> expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 6, p. 735, doi. 10.1002/mc.22794
- By:
- Publication type:
- Article
<italic>TET2</italic> expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 8, p. 5838, doi. 10.1002/jcp.26373
- By:
- Publication type:
- Article
Methylation‐independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 6, p. 4707, doi. 10.1002/jcp.26253
- By:
- Publication type:
- Article
Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 3, p. 2444, doi. 10.1002/jcp.26119
- By:
- Publication type:
- Article
Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.897898
- By:
- Publication type:
- Article
SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 4789, doi. 10.2147/OTT.S210168
- By:
- Publication type:
- Article
Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 3295, doi. 10.2147/OTT.S194549
- By:
- Publication type:
- Article
CEBPA methylation and mutation in myelodysplastic syndrome.
- Published in:
- Medical Oncology, 2015, v. 32, n. 7, p. 1, doi. 10.1007/s12032-015-0605-z
- By:
- Publication type:
- Article
Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia.
- Published in:
- Medical Oncology, 2015, v. 32, n. 1, p. 1, doi. 10.1007/s12032-014-0386-9
- By:
- Publication type:
- Article
Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0894-y
- By:
- Publication type:
- Article